News and Trends 6 Aug 2021 Artios’ €129M Series C Pushes Limits of DNA Repair in Cancer The UK firm Artios Pharma raised a huge Series C round last week in one of many efforts to develop cancer drugs that target the DNA repair systems of our cells. Artios Pharma bagged €129M (£110M) last week in a venture capital round led by the US-based firms Omega Funds and TCG X. The proceeds […] August 6, 2021 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
In Depth 4 Aug 2021 Ditch the VC: Alternative Funding Options for Biotech Startups Getting money for a biotech startup can be a daunting task. Venture capital is not the only — and not always the best — option to fund a life sciences company. “A lot of entrepreneurs, particularly young first-time entrepreneurs, think venture capital is the only way to build up a company,” said Andreas Schmidt. Ten […] August 4, 2021 - 9 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 3 Aug 2021 Oral and Nasal Covid-19 Vaccines Hit Clinical Testing Oramed’s jab-free oral Covid-19 vaccine is one of many in the form of pills, powders, or sprays that may hit the market in the next few years, which could dramatically expand vaccine rollout and uptake. An Israeli team is preparing to start trials of what could be the first Covid-19 vaccine pill. The vaccine consists […] August 3, 2021 - 5 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
Expert Advice 2 Aug 2021 The Path to Becoming a Chief Medical Officer in the Biotech Industry Life science researchers with an entrepreneurship inclination are often attracted to leadership positions with a focus on medical science. Daniel Chung shares his journey to becoming the Chief Medical Officer of the biotech startup SparingVision. Within a biotech company, a Chief Medical Officer (CMO) typically oversees and sets the company’s strategy and direction regarding the […] August 2, 2021 - 6 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jul 2021 British Diagnostics Biotech Becomes Social Enterprise After Acquisition UK rapid diagnostics company Mologic will convert into a social enterprise after being acquired by a group of philanthropic funds and investors, in what experts predict may become an increasingly popular trend. The British biotech Mologic will entirely reinvest any profits into widening global access to affordable medical technology after being acquired in a deal […] July 30, 2021 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jul 2021 Microbiome Medicines Could Power Up CAR-T Cell Therapies The microbiome could pave new cancer immunotherapy inroads for European biotechs, bolstered by preclinical findings that gut bacteria metabolites may help CAR-T cell therapies penetrate and kill solid tumors. A recent study conducted by researchers at Philipps-University Marburg, University Hospital Würzburg, and the Leeds-based company 4D Pharma showed that metabolites produced by the gut bacteria […] July 28, 2021 - 5 minutesmins - By Mark Zipkin Share WhatsApp Twitter Linkedin Email
In Depth 28 Jul 2021 Tracking Covid-19 Cases with Wastewater Testing Researchers have been using DNA testing technology to detect traces of the SARS-CoV-2 virus behind Covid-19 in wastewater streams in order to predict and prevent outbreaks locally. Wastewater testing can be a useful method to study the behavior of people living in a specific region. For example, a European study conducted back in 2014 looked […] July 28, 2021 - 5 minutesmins - By Sachin Rawat Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jul 2021 Europe’s TCR Therapy Scene Gains Traction with €40M Series B Swedish firm Anocca’s fundraising is the first major venture capital round to go to a European TCR therapy developer this year; another sign that the technology is gaining momentum. Last year was a busy one for companies developing cell therapies for cancer based on engineering T-cell receptors (TCRs), known as TCR or TCR-T cell therapies. […] July 26, 2021 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Opinion 26 Jul 2021 The Underlying Scientific Issues Making Biotech Startups Fail Biotech startups rely heavily on the science behind their products. There are a series of common scientific challenges that may initially be overlooked but can determine the success or failure of a young startup. Recently, a colleague drew my attention to a report about the top reasons a startup company might fail. After postmortems were […] July 26, 2021 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 21 Jul 2021 What the EU’s Single-Use Plastics Ban Means for the Bioplastics Industry A European directive banning a range of single-use plastics came into law this month. How are the new regulations impacting industrial biotech companies developing bioplastics? In an attempt to reduce staggeringly high levels of plastic pollution seen around the world, particularly in marine environments, the 27 EU member states and Norway agreed in 2019 to […] July 21, 2021 - 10 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jul 2021 Danish Dementia Startup Launches Amid Maturing Nordic Biotech Scene Muna Therapeutics debuted with the Danish biotech sector’s biggest-ever Series A round earlier this month. This showcases the rapid growth taking place in the biotech industry in the Nordic region. Muna Therapeutics’ €62M ($73M) investment was co-led by the Danish investor Novo Holdings through its early-stage arm Novo Seeds. The startup was first set up […] July 20, 2021 - 4 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
Expert Advice 19 Jul 2021 How to Protect Your Intellectual Property as a Biotech Startup Biotechs always start with great scientific ideas, but if you can’t protect them, you can’t see them through to execution. Companies need to start developing long-term intellectual property strategies almost as early as they are devising the ideas that need protecting. Experts say that the right intellectual property (IP) strategy for a new biotech depends […] July 19, 2021 - 9 minutesmins - By Mark Zipkin Share WhatsApp Twitter Linkedin Email